Search results for abx831123

Tigatuzumab, Abbexa, abx831123

Tigatuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TNFRSF10B/CD262, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Tigatuzumab is under investigation in clinical trial NCT00991796, CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC).